Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07052266 · ClinicalTrials.gov registry record · NA
Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening
A NA study of Hereditary Cancer Syndromes, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 550
- Enrollment target
- 5
- Study locations
NCT07052266 is a NA study of Hereditary Cancer Syndromes that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 550 participants. The trial reports 5 study locations across 1 state.
The verdict
NCT07052266, a NA study of Hereditary Cancer Syndromes, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 550 participants
- Enrollment target
- 5
- Study locations
Study Summary
The investigators hypothesize that pregnancy and preconception care may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal or preconception/fertility care. The goal is to evaluate the acceptability of BRCA1/2 testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention and be cost-effective, especially among underserved populations.
Conditions Studied
Interventions
- GENETIC MyRisk Hereditary Cancer Test
Study Locations (5)
New York
- Reproductive Medicine - Brooklyn
- NewYork-Presbyterian Weill Cornell Medicine - Brooklyn
- Reproductive Medicine - New York
- Weill Cornell Medicine - New York
- NewYork-Presbyterian Weill Cornell Medicine Queens - Queens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2025-09-02 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07052266
The ClinicalTrials.gov registry entry for NCT07052266 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hereditary Cancer Syndromes appearing as the primary indexed condition, and to 1 intervention - of which MyRisk Hereditary Cancer Test is the first listed.
NCT07052266 reports 5 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07052266 about?
NCT07052266 is a clinical study titled "Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening". The investigators hypothesize that pregnancy and preconception care may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal or preconception/fertility care. The goal is to evalu...
What is the current status of trial NCT07052266?
This trial is currently recruiting. It is a NA study. The enrollment target is 550 participants. The study started on 2025-09-02. Estimated completion is 2028-12.
What conditions does trial NCT07052266 study?
This clinical trial studies the following conditions: Hereditary Cancer Syndromes.
What interventions are being tested in trial NCT07052266?
The interventions under investigation include: MyRisk Hereditary Cancer Test (GENETIC).
Who is sponsoring clinical trial NCT07052266?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07052266 being conducted?
This trial has 5 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hereditary Cancer Syndromes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.